pHR_Gal4UAS_Blinatumomab_PGK_mCherry Citations (1)
Originally described in: Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors.Roybal KT, Williams JZ, Morsut L, Rupp LJ, Kolinko I, Choe JH, Walker WJ, McNally KA, Lim WA Cell. 2016 Oct 6;167(2):419-432.e16. doi: 10.1016/j.cell.2016.09.011. Epub 2016 Sep 29. PubMed Journal
Articles Citing pHR_Gal4UAS_Blinatumomab_PGK_mCherry
| Articles |
|---|
| Targeting SARS-CoV-2 infection through CAR-T-like bispecific T cell engagers incorporating ACE2. Dogan M, Kozhaya L, Placek L, Karabacak F, Yigit M, Unutmaz D. Clin Transl Immunology. 2022 Oct 21;11(10):e1421. doi: 10.1002/cti2.1421. eCollection 2022. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.